The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
An effort to transform the world of sports through steroid use doesn’t exactly seem to be bearing financial fruit.
An effort to transform the world of sports through steroid use doesn’t exactly seem to be bearing financial fruit.
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures.
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance-enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
The four-year-old firm’s latest fund is 60% larger than its second vehicle announced 18 months ago.